Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

Ayzenberg I, Hoepner R, Kleiter I

Therapeutics and Clinical Risk Management 2016, 12:261-272

Published Date: 19 February 2016